Apricity Health CEO and Co-Founder Lynda Chin, MD, discusses why equitable cancer care goes beyond diversity in clinical trial participation. We need to engage all patients in foundational genomic research as part of the solution to inform and develop cancer drugs that work for all patients.
Menu
